News

Substudies from the START study were presented at EACS in Barcelona. One of these studies was a lung function study that evaluated if there was any difference in changes in lung function tests and the risk of developing chronic obstructive pulmonary diseases between...

The combination of ritonavir boosted paritaprevir together with ombitasvir and dasabuvir is very effective in hepatitis C genotype 1 treatment including patients with cirrhosis. For genotype 4 the combination without paritaprevir is also very effective. The ...

In a South African observational cohort study the incidence of tuberculosis (TB) was followed in 74 076 HIV-infected individuals. The study period was 2004 to 2010. The TB incidence was compared in patients on antiretroviral therapy (ART) and patients not yet on ART...

In the district of Caió in Guinnea-Bissau in West Africa the incidence and prevalence of HIV-2 was measured 1990, 1997 and 2007. A mathematical model of the spread of HIV-2 was used to predict the future of the HIV-2 epidemic. The studies were done before the...

In a nationwide study the incidence of BPH in 4633 HIV positive Danish men was compared to three different control groups. The first control group consisted of 46330 age matched men, the second group of 1585...

Coinfected patients with tuberculosis (TB) and HIV were included in a study of raltegravir treatment during rifampicin containing TB therapy. After a median of six weeks of TB therapy patients were randomized to open label therapy with standard dose raltegravir 400...

In a proof of concept study the prenylation inhibitor lonafarnib in two different doses was compared to placebo in patients with HDV. Patients were given 100 mg, 200 mg or placebo twice daily for four weeks. HDV-titers declined significantly in a dose dependant...

The treatment options for patients with advanced kidney disease and hepatitis C are limited. In a study of the combination of a protease inhibitor (grazoprevir) and an NS5a inhibitor (elbasvir) patients with stage 4-5 kidney disease with or without haemodialysis...

When commercial tests for HIV antibodies became available in 1985 it was unclear how long time it takes from infection to seroconversion. A follow up time of 6 months after HIV exposure was recommended....

During treatment for hepatitis C (HCV) with sofosbuvir and simeprevir two patients reactivated hepatitis B. The first case was a 55 year old man with chronic e-antigen negative hepatitis B and genotype 1 HCV. He had evidence of cirrhosis and portal hypertension....

Pages